Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prolonged Oral Tranexamic Acid Use in Primary Total Joint Arthroplasty: A Double Blind Randomized Placebo Controlled Trial

NCT06894719 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT06894719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06894719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prolonged Oral Tranexamic Acid Use in Primary Total Joint Arthroplasty: A Double Blind Randomized Placebo Controlled Trial
Lead sponsor
Rush University Medical Center
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
May 1, 2027
Enrollment
351 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

total knee arthroplasty